{
  "name" : "moscow.sci-hub.se_4682_9b1e1cb96e26bd035b47c67ff3d59e54_ashraf2016.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Gold-Based Nanomaterials for Applications in Nanomedicine",
    "authors" : [ "Sumaira Ashraf", "Beatriz Pelaz", "Pablo del Pino", "M onica Carril", "Alberto Escudero", "Wolfgang J. Parak", "Mahmoud G. Soliman", "Qian Zhang" ],
    "emails" : [ "ashraf@staff.uni-marburg.de;", "carolina.carrillocarrion@physik.uni-marburg.de" ],
    "sections" : [ {
      "heading" : null,
      "text" : "Au NPs, such as their tunable size, shape, and surface characteristics, optical properties, biocompatibility, low cytotoxicity, high stability, and multifunctionality potential, among others, make them highly attractive in many aspects of medicine. First, the preparation methods for various Au NPs including functionalization strategies for selective targeting are summarized. Second, recent progresses on their applications, ranging from the diagnostics to therapeutics are highlighted. Finally, the rapidly growing and promising field of gold-based theranostic nanoplatforms is discussed. Considering the great body of existing information and the high speed of its renewal, we chose in this review to generalize the data that have been accumulated during the past few years for the most promising directions in the use of Au NPs in current medical research.\nS. Ashraf (*), B. Pelaz, M.G. Soliman, Q. Zhang, and C. Carrillo-Carrion (*) Fachbereich Physik, Philipps Universität Marburg, 35037 Marburg, Germany e-mail: ashraf@staff.uni-marburg.de; carolina.carrillocarrion@physik.uni-marburg.de\nP. del Pino CIC biomaGUNE, San Sebastian, Spain\nM. Carril CIC biomaGUNE, San Sebastian, Spain\nIkerbasque, Basque Foundation for Science, 48011 Bilbao, Spain\nA. Escudero Fachbereich Physik, Philipps Universität Marburg, 35037 Marburg, Germany\nInstituto de Ciencia de Materiales de Sevilla, CSIC-University of Seville, 41092 Seville, Spain\nW.J. Parak Fachbereich Physik, Philipps Universität Marburg, 35037 Marburg, Germany\nCIC biomaGUNE, San Sebastian, Spain\nKeywords Diagnostics • Gold nanoparticles • Nanomedicine • Theranostics • Therapeutics\nContents\n1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 170 2 Synthesis and Functionalization of Au NPs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 172\n2.1 Synthesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 172 2.2 Functionalization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174 3 Use of Au NPs Towards Diagnostics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 175\n3.1 Detection and Sensing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 175 3.2 Imaging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 179 4 Use of Au NPs in Therapeutics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 183\n4.1 Au NPs as Passive Carriers in Delivery Systems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 183 4.2 Au NPs as Active Therapeutic Agents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 185 5 Use of Au NPs Towards Theranostics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 190 6 Applications of Au NPs in Clinical Trials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 193 7 Concluding Remarks and Future Outlook . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 194 References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 195"
    }, {
      "heading" : "1 Introduction",
      "text" : "In recent years, there has been an unprecedented expansion in the field of nanomedicine, which involves the development of novel nanoparticles (NPs) envisaged for the diagnosis and treatment of several diseases, especially cancer. NPs possess extraordinary capabilities to detect, image, and potentially treat diseases at the cellular and molecular levels [1–7]. Although micelle-based NPs (such as formulations loaded with doxorubicin, paclitaxel, or cisplatin) [8] are most advanced towards use in clinical practice, inorganic NPs also offer great potential. Among various inorganic NPs, Au NPs are important examples in the field of nanomedicine, thanks to their chemical, physical, and optical properties [9–13]. Their unique physical and chemical properties, such as inertia, biocompatibility, low cytotoxicity, stability against oxidation and degradation in vivo, and ease of conjugation to biomolecules, provide significant benefits in comparison with other NPs from a medico-biological point of view. The optical properties of Au NPs are determined by the so-called localized surface plasmon resonance band (LSPR) [14], which is associated with a collective excitation of conduction electrons. Depending on the size, shape, structure, and the NPs environment, the LSPR can be localized in a wide region from the visible to the infrared. Implementation of different surface chemistries enables them to have high stability, high carrier capacity, ability to incorporate both hydrophilic and hydrophobic substances, and compatibility with different administration routes. Because of the nano-size, Au NPs have good tumor retention capabilities as they can penetrate the leaky tumor vasculature. These properties make Au NPs interesting materials for sensing,\ndetection, imaging, targeted delivery of drugs and genes, photo-induced therapies, enhanced radiotherapy, and so on. Furthermore, the multifunctionality potential of Au NPs provides an ideal platform for developing the theranostic modalities combining therapeutic, targeting, and imaging functions, demonstrating synergistic effects of multi-therapies. Figure 1 shows a simplified scheme of different areas of research where Au NPs are involved in the development towards nanomedicine. The evolution of research has progressed from the synthesis and functionalization towards applications. The evolution started with simple and unimodal applications towards more complex multimodal applications (e.g., multimodal imaging, dualmode therapies, etc.). The latest development is focused on theranostics nanoplatforms, which can diagnose, deliver targeted therapy, and monitor response to therapy. Although the natural evolution is from the bottom to the top (as drawn in the scheme), in parallel (i.e., in transversal mode), studies of toxicity and bio-distribution are key aspects to guarantee the success of their applications. These studies and results of the application performances have a direct feedback in synthesis and functionalization for improvements. These inputs are the reason why new strategies of synthesis are an area of continuous active research.\nThe following sections describe some recent advances in the different areas of research using Au NPs, mainly focusing on their potential for medical applications and the hurdles to be overcome to translate them into clinical trials. Bio-distribution\nand toxicity have been extensively reviewed and discussed in a number of recent publications [15–18], and thus we discuss it in the conclusions section. As the topic of this review involves huge amounts of information with a high speed of renewal, we focus on major ideas and some of the most recent and promising studies performed during the past few years."
    }, {
      "heading" : "2 Synthesis and Functionalization of Au NPs",
      "text" : ""
    }, {
      "heading" : "2.1 Synthesis",
      "text" : "Before the advent of nanoscience, Au NPs were already attracting interest because of their optical properties. There are many historical examples in which Au NPs were applied even without knowing it (e.g., the Lycurgus Cup or stained-glass windows). In the last few decades, the control in the synthesis of Au NPs has evolved greatly. Nowadays it is possible to produce Au NPs with different sizes and shapes in a highly controlled manner. Many reviews and book chapters have already been published about the state- of‐ the- art of Au NPs synthesis [13, 19–22]. Thus, here we aim to provide an overview of some of the most recent achievements in the synthesis of Au NPs using wet- chemistry (though also other routes such as laser ablation exist [23]).\nMost wet-chemistry-based Au NPs are synthesized in aqueous media, but there are some important examples to produce hydrophobically-capped Au NPs (e.g., the Brust–Schriffin method) [24]. These NPs are typically spherical with a size less than 10 nm. It is well known that most of the applications of Au NPs in nanomedicine are based on their optical properties, i.e., LSPR [25]. The desire for tuning of the LSPR has been a driving force to develop synthesis strategies allowing for Au NPs of different sizes and shapes. Although controlled synthesis of Au NPs has been known since the days of Michael Faraday, most synthetic strategies to produce water soluble spherical Au NPs are based on the Turkevich method [26]. This method has been continuously improved to produce better samples (e.g., with narrow size distribution and more homogeneous NPs). This optimized methodology also allows the growing of Au NPs of sizes up to 200 nm [27]. Yet arguably the most interesting Au NPs for bio-applications are anisotropic Au NPs that exhibit their LSPR in the biological window. This biological window comprises the spectral region of 700–1100 nm, in which the body tissue components absorb less light. This range is therefore the desired region to locate the LSPR of Au NPs intended to be used for bio-applications (e.g., photothermal therapy (PTT) [28, 29] or optoacoustic imaging (OAI) [30]). Recent controls over shape during the synthesis of Au NPs make it possible to tune the position of the LSPR by changing parameters such as the shape (rods, prisms, etc.) [28, 31] or the structure of the NPs (e.g., hollow vs homogeneous) [32]. To induce the growth of anisotropic NPs it is necessary to provoke either a kinetically controlled growth of the NPs or to induce the blocking of some growing facets [33]. The sphere is the most stable\nshape in terms of energy. If the NPs synthesis is performed under thermodynamically controlled conditions, the NPs obtained are spherical. In general, to obtain non-spherical NPs the synthetic conditions have to be tuned to induce kinetically controlled NPs growth. This can be performed using surfactants that block some growing facets (e.g., cetyltrimethylammonium bromide (CTAB) or polymers) [34], using halides (e.g., Br , I ) [35] or weak and mild reductants (e.g., Na2S2O3) [28]. To date, Au nanorods remain the most broadly used anisotropic NPs. These rod-shaped NPs were described almost at the same time by the groups of El-Sayed [36, 37] and Murphy [28]. Since then, the synthesis of these NPs has been deeply explored. In general, the synthesis of Au nanorods is performed by using the growth seeding process. First, small spherical Au NPs are synthesized and then added to the growing solution rich in CTAB to induce rod-shaped growth. Because of the cytotoxicity of CTAB [38], Murray et al. have recently developed a modified Au nanorods synthesis method in which the required CTAB concentration is reduced by half (from 0.1 M from El-Sayed and Murphy to 0.05 M) [31, 39]. This synthesis is based on the use of aromatic additives.\nAnother important type of anisotropic NPs is the Au nanoshells developed by Halas et al. [40]. These structures are built using a silica core in which gold is grown. Their LSPR can be modulated by controlling the relationship between the core size and the thickness of the gold shell. By changing the shape of the core, other similar structures have also been described such as “nanorice” [41]. Halas et al. also described a synthesis for “nanomatryushkas,” which are multilayered spheres. The simplest “nanomatryushka” contains a core of a gold sphere of ca. 40 nm coated with a SiO2 shell and a second shell of Au [42]. Several bilayers of SiO2 and Au can be deposited to obtain more complex “nanomatryushkas.”\nAu nanoprisms also have been described. The synthesis of triangular nanoprisms can often only be achieved with a low yield [43] and by using toxic surfactants (e.g., CTAB or CTAC (cetyltrimethylammonium chloride)) [44]. A synthesis route eliminating the use of toxic surfactants has recently been reported, which allows for tuning the LSPR position by controlling the amount of reductant. This synthesis is based on the reduction of a gold salt by thiosulfate (Fig. 2a) [28].\nAu nanostars also exhibit their LSPR in the biological window. Many different synthetic procedures to produce Au nanostars have been reported. For generating Au nanostars, typically the seed-growing method is used. For instance, Liz-Marzán et al. published a method in which gold salt was reduced to metallic gold on top of the 15-nm Au NPs stabilized with poly(vinylpyrrolidone) (PVP) in the presence of dimethylformamide and PVP [45].\nFinally, Au nanocages, originally developed by the group of Y. Xia, have been applied extensively with different purposes in nanomedicine [46, 47]. These cages are prepared by using a sacrificial silver nanocube, which then is oxidized to promote the reduction of gold through a galvanic replacement process. Similar approaches have been described using silver nanospheres [48] and silver nanoprisms [49].\nAiming to use green chemistry and less toxic reagents, the production of Au NPs using natural extracts from microorganisms (e.g., micro alga [50] or fungi [51]) or plants has been also explored [50, 52]. Nevertheless, the yield and quality of these Au NPs is still far below the quality of the previously described approaches.\nAu-based hybrid materials have been developed too, trying to combine the great optical properties of gold with the properties of another material. Several examples of core-shell structures of Au containing iron oxide [53–55] or semiconductors cores [54] or Au cores coated with silver (bimetallic NPs [56]) can be found in the literature. More recently, Au has been combined with more novel materials such as nanodiamonds [57] or graphene [58, 59]."
    }, {
      "heading" : "2.2 Functionalization",
      "text" : "After synthesis and before their use in bio-applications, NPs must be provided with stable coatings which should warrant high colloidal stability. Thus, robust organic coatings ensure that the NPs’ properties remain intact in biological media [60]. Indeed, the NPs surface determine their biological fate [61]. In addition, any kind of by-product related to the synthesis, including excess of reagents or cytotoxic surfactants, should ideally be washed off to remove potential toxic effects caused by these impurities. To achieve coatings qualifying for these requirements, the NPs’ surfaces need to be engineered. One of the biggest advantages of the use of Au is its high reactivity with thiol groups [62]. This reactivity permits stabilizing the NPs with ligands containing a thiol reactive group. Ligand exchange by which original surfactants are replaced by new ones is the most common stabilizing procedure for Au NPs. Ligand exchange can be used to water transfer hydrophobically-capped NPs (e.g., NPs capped with alkanethiol chains) [63] and to replace toxic surfactants (e.g., CTAB) used to produce anisotropic NPs such as Au nanorods [64, 65].\nTypically, polyethylene glycol (PEG) chains which provide the NPs with a colloidal high stability in biological media and long in vivo retention times [19, 66] are the most widely used stabilizers for Au NPs. Nowadays, there are many companies which offer an endless number of hetero-functional PEG chains. Using bi-functional PEG allows for future chemical modifications for the attachment of molecules (e.g., dyes, carbohydrates, antibodies, peptides, etc.) and/or to provide charge to the NPs (Fig. 2a) [28, 67, 68]. Not only PEG is used to stabilize Au NPs – other ligands, such as dihydrolipoic acid [69], proteins (e.g., bovine serum albumin) [70], or polymers are used regularly to enhance the NPs’ stability in complexes media. Polymers used for this purpose include, for example, polyelectrolytes [71], PVP [72], or amphiphilic polymers [73].\nThe use of amphiphilic polymers to stabilize NPs and to promote their transfer from organic solvents to aqueous solutions is based on polymer coating of the NPs. This approach can be used for virtually any kind of NPs containing aliphatic chains on the surface (e.g., oleic acid, oleylamine, etc.) [73, 74]. The advantages of this technique are many: (1) coated NPs exhibit a high colloidal stability against media with high salt concentrations and/or proteins; (2) NPs coated with the same polymer have the same surface chemistry; (3) these polymers can be made with reactive groups in their hydrophilic domain (e.g., carboxylic acids), which then can be further modified with biologically relevant molecules. The main limitation of this technique is that it can be only used with NPs soluble in organic solvents. Yet most of the anisotropic Au NPs are synthesized in water. An extension of this method based on phase transfer of the water-soluble Au NPs to organic solvents has recently been reported. This method has been demonstrated for spherical Au NPs (with size up to 15 nm) and Au nanorods (Fig. 2b) [75].\nOnce Au NPs are sufficiently colloidally stable in biological media, as a function of their surface chemistry, different chemical modifications can be performed. Bioconjugate chemistry protocols developed for modifying proteins, peptides, and/or surfaces can be adapted to NPs [76, 77]. Concerning bio-conjugation, we refer to some recent reviews [11, 78–80]. In summary, currently the synthesis and functionalization of Au NPs has become very versatile. This allows scientists to develop the best customized systems for each application."
    }, {
      "heading" : "3 Use of Au NPs Towards Diagnostics",
      "text" : ""
    }, {
      "heading" : "3.1 Detection and Sensing",
      "text" : "Different analytical assays involving Au NPs are widely used as sensors, ranging from the detection of ions and elements to more complex molecules, including those of biomedical interest, such as oligonucleotides, proteins, antibodies, and even bacteria and other microorganisms. The methods of designing sensing biomarkers that could be associated with the early stage diagnosis of different diseases\nare nowadays attracting special interest. The current challenges consist of designing sensing devices that are able to recognize more specifically different types of analytes, discriminating molecules with similar characteristics, including the use of sensor arrays, which often combine several analytical approaches. Advances in enhancing the sensitivity and reducing the time of analysis are also currently required. The physical and analytical basis of sensing with Au NPs can be summarized in different main areas [81]. They include measurements based on colorimetry and plasmon resonance, fluorescence, electrochemistry, and more recently, surface enhanced Raman spectroscopy (SERS) [82].\nColorimetric assays are based on a visible change of color of functionalized Au NPs suspensions when interacting with the appropriate analyte [83–86]. Colorimetric analyses are normally fast and can often be evaluated with the naked eye. As explained before, Au NPs exhibit plasmonic properties. The position and intensity of this LSPR band depend not only on the metal type, NPs size, shape, structure, composition, and dielectric constant of the surrounding medium [87], but also on the aggregation of the NPs [88]. Colorimetric assays are based on this effect, because analytes that produce a change in the aggregation state of Au NPs give rise to a change in the LSPR absorption band of the NPs dispersion [89]. Such an effect is not only used to sense cations and anions [89–92], but has also been applied to sense molecules of biomedical interest. For example, DNA has been detected by Au NPs wrapped with long genomic single- and double-stranded DNA (ssDNA and dsDNA) molecules [93]. Proteins such as melamine and human carbonic anhydrase II have also been sensed by cyanuric acid derivative grafted Au NPs [94] and polypeptide-functionalized Au NPs [95], respectively. More complex molecules such as folate receptors (FRs), consisting of cysteine-rich cell-surface glycoproteins that can bind folate (FA), can be sensed by FA-modified ssDNA functionalized Au NPs. In the presence of FRs, ssDNA terminally tethered to FA is protected from degradation by exonucleases, and an aggregation of the Au NPs takes place through the formation of cross-linked NPs networks, resulting in a color change of the solution from red to blue [96]. Polyethyleneimine (PEI)-stabilized Au NPs have been used for highly selective and sensitive colorimetric sensing of heparin [97]. Abnormal concentration values of human chorionic gonadotropin (hCG) can be associated with ectopic pregnancy. The concentration of this biomarker can be determined using Au NPs in the presence of positively charged hCG-specific peptides. In this case, hCG inhibits the peptide-induced aggregation of the Au NPs, giving rise to a simple, rapid, and sensitive colorimetric assay [98]. A rapid and low-cost colorimetric analysis of bacteria in drinking water has been designed by using β-galactosidase conjugated Au NPs with a colorimetric substrate (chlorophenol red-β-D-galactopyranoside (CPRG)) deposited on a paper-based test strip [99]. The aggregations of antibody-conjugated oval-shaped Au NPs that selectively target specific sites on the surface of pathogens have been used to sense Salmonella [100]. Although colorimetric assays based on Au NPs involve the large shift of the LSPR band depending on NPs aggregation, a small LSPR peak shift can also be produced when an appropriate analyte binds to the surface-bound receptors of plasmonic NPs, because of a change in the refractive index [101]. In contrast to\nagglomeration-based protocols, this shift in the LSPR frequency is not enough to be detected by the naked eye, but can be observed by absorption measurements. Au NPs deposited on several substrates have been used to detect analytes such as DNA [102], human IgG (Immunoglobulin G) [103], and insulin [104] in this way. Recent advances in the detection of microRNAs (miRNAs) by Au nanoprisms without the need for labels [105] and in the sensing of trace oligonucleotides biomarkers [106] have also been reported. Au NPs deposited on the metal sensing surface increase the sensitivity of planar surface plasmon resonance sensors, provided by the high dielectric constants of Au NPs and the electromagnetic coupling with the metal film [107]. This approach has been used for the sensing of different proteins [108] and oligonucleotides [108, 109].\nFluorescence assessments involving Au NPs are widely centered on fluorescence quenching-based methods. Au NPs show an important quenching effect on fluorophores close to their surface caused by their extraordinary high molar extinction coefficients and broad energy bandwidths [83, 110]. Specific interactions with the sensing molecules have been used to detect many different molecules of biomedical interest. Some assays are based on the appearance of fluorescence when the target molecules interact with the Au NP-based-sensors. For example, the quenching of a fluorophore attached to an Au NP through an oligonucleotide chain disappears in the presence of DNA [111], when the fluorophore gets detached from the NPs because of displacement by the DNA strand. Similar strategies have been used to sense proteins [112] and bacteria [113] using Au NPs conjugated with fluorescent polymers. Au NPs functionalized with enzymes have also been used to sense proteins, with an enhanced sensitivity through enzymatic catalysis [114].\nFluorescence quenching assays involving Au NPs are not only restricted to the detection of single analytes. More complicated sensing techniques, focused on the study of the interaction of different analytes, have also been reported. For example, dsDNA-conjugated Au NPs (dsDNA-Au NPs) and water-soluble conjugated polyelectrolytes are used as complementary sensing elements to construct hybrid sensors for detecting protein–DNA interactions [115]. The use of sets of sensors showing different patterns of responses in an array can provide fingerprints that allow for classification and identification of different target molecules [116]. Such an approach is used with DNA–Au NPs conjugates, in which a combination of colorimetric and fluorescence assessments enables better selectivity to distinguish different proteins [117]. Similar combination of colorimetric and fluorometric approaches has been reported for a sensor array consisting of two types of novel blue-emitting collagen-protected Au nanoclusters and macerozyme R-10-protected Au nanoclusters with lower synthetic demands, which has been recently used to sense eight different proteins [118].\nThe modulation of quenching of fluorescent semiconductor quantum dots (QDs) close to Au NPs in the presence of molecules which inhibit the interaction between QDs- and Au NPs-conjugated biomolecules has been used to sense molecules of biomedical interest such as avidin [119]. Normal, cancerous, and metastatic human breast cells have been distinguished by comparing the fluorescence of different\ncationic Au NPs functionalized with poly( p-phenyleneethynylene) (PPE), which show different affinities for normal and tumor cells [120].\nThe conductivity, roughening of the conductive sensing interface, and the catalytic properties of Au NPs have been harnessed for the huge amount of analytical assays based on electrochemical measurements that involve Au and other metal-based NPs [121]. Different immunosensors based on Au NPs have recently been reported to detect cancer biomarkers [122, 123]. Au NPs deposited on electrode surfaces are known to enhance the electrochemical detection of different analytes because of their ability to decrease the overpotentials of many electroanalytical reactions, maintaining the reversibility of redox reactions [124, 125]. This approach has been used to detect several drugs such as isoniazid [126] and hCG [127]. Au nanorods have also been used as sensing interface in pencil graphite electrodes for the electrochemical sensing of deferiprone, an anti-HIV drug, resulting in an amplification of the electrochemical sensing signal [128].\nAntibody-functionalized Au NPs, showing target specificity and affinity towards different biomarkers [129], have been used to sense Salmonella by differential pulse voltammetry (DPV) [130]. Cancer circulating cells have been sensed by combining the specific labeling through antibody-modified Au NPs and the sensitivity of the Au NPs-electro-catalyzed hydrogen evolution reaction (HER) detection technique [131]. The reaction of cell surface proteins with specific antibodies conjugated to Au NPs and the catalytic properties of the Au NPs on hydrogen formation from hydrogen ions can be used to quantify the NPs internalized by cancer cells [132, 133].\nRaman scattering permits the detection and analysis of many molecules, by giving a unique spectroscopic signature which potentially identifies the species [134]. The Raman scattering signal can be substantially enhanced by the presence of plasmonic NPs, resulting in SERS [135, 136]. This effect is highly influenced by the size, shape, orientation, and aggregation of the NPs [108]. In fact, Au NPs with different morphologies have been used for SERS-based detection [137– 139]. Label-free and Raman-dye labeled assays are two different existing SERSbased detection methods. Label-free assays follow vibrational information about the analytes themselves, whereas the dye-labeled methods detect analytes indirectly by monitoring the SERS signal of a Raman label attached to the metallic SERS substrate [140]. Different SERS assays for sensing DNA [141, 142] and proteins [143, 144] using Au NPs can be found in the literature. An extended bi-dimensional array of Au concave nanocubes supported on a polydimethylsiloxane (PDMS) film has recently been proposed for the SERS sensing of proteins that show low intensity Raman signals [145]. The assembly of spherical Au NPs on a highly anisotropic silica-coated substrate has recently been reported for the detection of prostate specific antigen by SERS [146] and the selectively quenching of the SERS signals from the dye molecules adsorbed onto star-shaped Au NPs not internalized by cells has been used to identify intracellular distributions of Au NPs [147]."
    }, {
      "heading" : "3.2 Imaging",
      "text" : "For the treatment of many diseases and non-invasive evaluation/detection of intracellular and/or intra-subcellular compartments, molecular imaging based on functional nanomaterials is of paramount importance [148, 149]. For molecular imaging, different types of NPs are currently in use. Examples include polymer-based NPs [150–152], dendrimer-based NPs [153, 154], lipid-based NPs [155, 156], magnetic NPs [157–160], QDs [161–163], carbon nanotubes (CNTs) [164, 165], silica NPs [166–168], and Au NPs [169–172]. Among all the above-mentioned NPs, Au NPs possess extraordinary potential for imaging at the cellular and even molecular level. Various Au NPs are currently in use in molecular imaging, based on their different size, shape, and physical properties. Examples include spherical Au NPs [171, 172], nanorods [173–175], nanobipyramids [19], nanoshells [176], nanocages [177–179], core/shell NPs [171, 180], nanostars [181–183], and nanocubes [149], etc.\nAu NPs have unique characteristics which enable their use as contrast agents in bio-medical imaging [184, 185]. In this field, they are being used as probes in dark field confocal imaging (DFCI), one- and two- photon fluorescence imaging (OTPFI), optoacoustic imaging (OI), computed tomography (CT), photothermal optical coherence tomography (POCT), positron emission tomography (PET), and imaging based on surface enhanced Raman scattering (SERS) [175, 184]. Different imaging modalities of the Au NPs can be combined, which can provide complementary information. In the following, a description of using Au NPs as contrast agents for the different imaging techniques is given.\nDFCI provides contrast enhancement in unstained biological samples, but its main limitation is that it provides low light levels in images. Thus, for better visualization the biological samples should be strongly illuminated, which can, however, damage the samples. The imaging contrast of dark field microscopy can be enhanced by utilizing the high scattering properties of Au NPs [186]. For cellular detection, mostly the light scattering properties of Au NPs are utilized for straightforward image analysis. Light scattered from Au NPs is detected by using high resolution objective lenses of dark field confocal (DFC) microscopes in the form of bright spots, though the size of Au NPs is generally smaller than the diffraction limit of DFC. Using Au nanoshells it was recently possible to observe the binding and antibody mediated specific targeting of cancer cells in in vitro experiments using the dark field scattering properties of the NPs [187]. Similarly, for cancer cells localization, targeting, and real time tracking of Au nanorods-induced DNA damage in cancer cells was visualized using DFCI [188]. Scattering properties of Au NPs are also being utilized for better imaging of breast cancer cells [189]. However, despite the high scattering cross sections of Au NPs for enhancing the contrast in DFCI, their use is limited to in vitro experiments [184].\nPhotoluminescent properties of sub-nanometer Au nanoclusters made them attractive candidates in OTPFI based on their brightness, non-blinking behavior and stable emission [190, 191]. The luminescence of Au nanoclusters in the near\ninfrared (NIR) window is used for fluorescence imaging and they have greater photostability than QDs [191]. Not only nanoclusters but also other Au NPs, such as nanoshells and nanostars, can be used in one photon fluorescence imaging (OPFI), after conjugation of the Au NPs with NIR active fluorophores such as indocyanine green or Cy5 [192]. After conjugation with these fluorophores, these structures help in emission enhancement of these dyes for better fluorescence imaging. Presence of a metal surface close to fluorophores does not always quench fluorescence, but can also provide fluorescence enhancement, in particular for very close distances. In OPFI, Au NPs functionalized with fluorophores, offer a suitable platform for in vitro and in vivo cancer imaging and diagnostics [193, 194]. When Au NPs are excited with femtosecond pulsed lasers whose resonance frequency matches with the LSPR band of the Au NPs, two photon absorption occurs which results in two photon luminescence from the Au NPs [182, 193, 195]. For monitoring in vivo biological events, two photon luminescence imaging (TPLI) provides sufficient penetration depth and high three-dimensional (3D) spatial resolution. The signal intensity of TPL (two photon luminescence) can be enhanced three times in magnitude by utilizing the high luminescent properties of Au nanorods and nanocages without the photo-bleaching or blinking that is observed in many fluorophores used in this technique [196]. The contrast of Au nanostars conjugated with wheat germ agglutinin in TPL-based imaging can be utilized for imaging their uptake [182]. Similarly, other Au NP structures, such as nanorods, nanocages, and nanoshells, are also being used as contrast agents in TPL with a resolution at the single NP level inside blood vessels. In this way, in vivo tracking of Au NPs and fluorescence lifetime imaging for visualizing dynamical processes in cell media is possible [197, 198]. After one and two photon luminescence-based imaging, Au nanocages are now also being utilized in three photon luminescence imaging, based on their strong multi-photon absorption capabilities, leading to in vivo detection with diminished background signals and reduced photothermal toxicity [199]. Further studies are still required for using Au NPs in multi-photon luminescence for a better understanding of their role in this imaging technique.\nThe penetration depth of OI-based imaging, which is typically carried out with NIR pulsed sources, is similar to ultrasound-based imaging, i.e., several centimeters in biological tissues (typically less than 5 cm). This is better compared to simple optical imaging, in which depth resolution is only on the millimeter scale. The photothermal properties of Au NPs provide high contrast in OI [30]. Upon photoexcitation, the non-radiative decay of Au NPs converts light energy into heat, which causes a sharp rise of temperature in the local environment of the NPs, resulting in thermal and acoustic response enhancement in those tissues which contain the photoexcited NPs. The increased thermal response of Au NPs enhances the pressure waves propagating through the surrounding tissues and results in improving the temporal and spatial resolution of tomographic images [200].\nIn clinical detection of several diseases, CT has received increasing attention because of the high spatial and density resolution. For imaging biological systems using CT, contrast agents are usually required (which can enhance the density of the imaging area) for improving the accuracy in diagnosis. Iodine-based small\nmolecules such as “Omnipaque” are normally used in clinics, but are associated with certain drawbacks such as short imaging time, non-specificity, and renal toxicity. For overcoming these drawbacks nowadays, Au NP-based suitable contrast agents are being developed. In CT, because of the high atomic number of Au, Au NPs are providing higher spatial and density resolution compared to iodinebased contrast agents. In CT-based imaging, Au NPs attenuate X-rays much more efficiently compared to “Omnipaque,” resulting in contrast enhancement by several orders of magnitude [201, 202]. Moreover, by suitable tuning the size and functionalization of the Au NPs, besides improving CT imaging it is also possible to achieve target specificity, long circulation time, and reduced renal toxicity [203].\nOptical coherence tomography (OCT) can image cellular and sub-cellular structures 100 times better than CT and magnetic resonance imaging (MRI) and provides 10–25 times better spatial resolution compared to ultrasound-based images [204]. OCT is a non-invasive technique, resembling ultrasound-based imaging but, in this technique, instead of sound, reflections of NIR light are used for imaging. NIR active contrast agents, e.g., Au nanorods, can significantly improve OCT-based imaging because of their large differences in absorption-scattering profiles. Au nanoshells and nanocages, because of their strong scattering properties, can also provide enhanced optical contrast and brightness in OCT for improving the imaging of cancerous cells [205]. In this technique, tissues are illuminated with low coherent light and matching the coherence between incident and reflected beams of light helps in the detection of back-reflected light. This backscattered light thus helps in imaging. Because OCT is much more sensitive towards detection of scattering from the tissues than absorption, the scattered light helps in studying the morphology of tissues [205]. In OCT, Au NPs are being used as exogenous contrast agents based on their ability to produce distinctive backscattered light which is detectable in highly scattering tissues, thereby helping in studying the morphology of tissues [206]. Though OCT is a powerful 3D diagnostic tool in real time imaging, its resolution is low because of intense scattering from some optically dense tissues under investigation. To overcome this limitation nowadays, POCT (photothermal-OCT) imaging techniques using the photothermal properties of Au NPs are being developed [207]. In POCT, when light resonant with the plasmon energy of Au NPs strikes, Au NPs are excited and light is converted into heat and the surface temperature of the tissues is enhanced. The increase in surface temperature results in changes in the local refractive index of the medium which is then optically detected by POCT. Because of active detection of photothermal heating, POCT can identify and separate absorbing targets from scattering background, thereby helping in high resolution imaging compared to OCT [208].\nIn early stage diagnosis of cancer, PET – with its highly sensitive nuclear imaging modality – is extensively utilized in clinical studies using small doses of radioactive materials. However, these radioactive materials, especially small radioactive molecules, usually have short circulatory life- times in in vivo studies. After radiolabeling, Au NPs (e.g., nanocages, nanoshells, and spherical NPs) can remain inside the bloodstream for longer periods of time. Hence they facilitate long-term\nbio-imaging [209]. In PET, radioisotopes undergo positron emission decay or positive beta decay and positrons are emitted. These emitted positrons traverse a short distance inside tissues, lose kinetic energy, and interact with electrons. This union with electrons results in their annihilation and production of gamma photons in the form of light which is used for making images [209]. Sometimes PET is coupled with Cerenkov luminescence (CL)-based imaging for better visualization and cross-checking the imaging results. CL-based imaging is a molecular imaging technique based on Cerenkov radiation, which can originate from the decay of alpha-, beta-, or positron-emitting radionuclides [179]. Recently, a radiolabeled precursor of a gold salt (H198AuCl4) was used for the synthesis of radioactive Au nanocages which gave CL. The CL originating from the decay of radionuclides helps in real-time CL-based imaging and monitoring of tumors over extended periods of time. CL of radionuclides can be increased by using high refractive index materials such as gold in conjugation with higher energy radionuclides. Thus CL imaging based on Au NPs can effectively bridge the gap between nuclear and optical imaging [179]. CL-based imaging can use radionuclides for diagnosis of diseases, which are routinely used for PET based imaging. CL based imaging improves PET-based imaging in terms of resolution. CL imaging signal can be modulated by using smart imaging agents such as NPs, and hence better insight in tumor biology can be obtained [210]. Over the last decade there have been numerous studies for enhancing the efficacy of SERS-based molecular imaging using Au NPs conjugated with Raman active moieties. Au NPs enhance the Raman scattering of vicinal molecules by means of chemical and electromagnetic enhancements. Au NPs enable identification of single molecules spectroscopically at room temperature by amplifying (ca. 1015-fold) the Raman scattering signals of adsorbed species. The LSPR of Au NPs enhances Raman signals in SERS-based imaging, which helps in better detection of tumor margins during the surgical removal of tumors [211]. The use of Au NPs provides photostability, improved contrast, and higher spectral specificity in SERS-based imaging [184].\nAmong all enlisted imaging techniques, no single modality can be considered as ideal and sufficient for getting all requisite information for a particular question. Nowadays, multimodal imaging probes based on Au NPs are being designed which possess integrated or complementary functions. For example, SERS-based imaging is highly sensitive and multiplexed imaging is possible with this technique, but it has poor penetration depth. On the other hand, OI has better penetration depth and high spatial resolution, but its sensitivity is limited. For multiplexed imaging, Au nanorod-based SERS/OI can be used for early stage detection of cancer. Similarly, Au NPs having triple modality are being used for MRI/SERS/OI-based imaging [212]. For disease (particularly cancer) intervention, Au NP-based multifunctional/ multimodal imaging platforms have enough potential for the development of future contrast agents useful for nanomedicine. One can envision the potential applications of Au NPs for multiplexed detection and imaging of cancer and other such types of diseases by proper tailoring of their functionalization, size, shape, composition, and hybridization with other materials [184]."
    }, {
      "heading" : "4 Use of Au NPs in Therapeutics",
      "text" : "The properties of Au NPs can be exploited in therapy in two ways – as passive carriers for delivery, in which the therapeutic effect arise from active molecules bound to the carrier, or as active therapeutic agents, where the therapeutic effect directly originates from the Au NPs. The first use of Au NPs for therapeutic applications was as delivery vehicles for drugs and genes, because NPs in the size range 2–100 nm can interact with biological systems at the molecular level, and can allow for targeted delivery and passage through biological barriers. Later on, also investigations showing that Au NPs can be intrinsically therapeutic became available. This is because Au NPs can actively mediate molecular processes to regulate cell functions. In this section we summarize the potential of Au NPs in therapy, providing examples of currently investigated strategies."
    }, {
      "heading" : "4.1 Au NPs as Passive Carriers in Delivery Systems",
      "text" : "Au NPs are widespread in the field of delivery of different kinds of therapeutic molecules. They are very attractive as nanocarriers because of their colloidal stability, ease of preparation, and their on-demand tunable size and surface modification possibilities. In addition, they are essentially bio-inert, non-toxic and lack immunogenicity. All these features in combination with their ability to enter cells by endocytic pathways naturally make them good vehicles for a plethora of biomolecules and drugs to be delivered inside cells [13, 213]. Normally, the cargoes are loaded onto the Au NPs’ surface either by non-covalent binding (via ionic or hydrophobic interactions) or by direct binding on the Au surface by thiolated linkers. Once inside the cells, the cargo may slowly detach from the surface of the Au NPs or its release may be triggered by internal stimuli such as pH [214] or cytosolic glutathione [215], which is able to reduce disulfide bonds, releasing molecules linked to the NPs surface via that kind of linkage. Furthermore, Au NPs are well known for their optical properties which are not only useful in the field of imaging and biosensing, but also serve to detach molecules selectively from the NPs surface when irradiated with light. Upon irradiation of plasmonic Au NPs at their LSPR frequency with a continuous wave laser, they absorb energy and reduce the attraction between the Au surface and non-covalently linked molecules, which eventually produces desorption of the cargo. In contrast, high energy pulse irradiation provokes the reshaping of the nanocarriers and the rupture of Au–S bonds, releasing more strongly linked cargoes. Interestingly, light irradiation of plasmonic nanomaterials allows for spatio-temporal controlled release of drugs and biomolecules because the delivery only takes place during irradiation of the NPs and stops when the laser is off [216–218]. The most commonly used Au NPs for delivery applications are nanospheres, and nanorods.\nAu NPs have been used for decades for the purpose of gene delivery, traditionally developed for the transfection of plants using gene guns [219]. Nowadays, Au NPs are also used in gene therapy as non-viral carriers for delivering nucleic acids inside the cells [220]. Gene therapy may include the delivery of DNA inside cells to induce certain protein expression, or the introduction of miRNA able to interfere with the correct translation of messenger RNA inside the cells, avoiding protein production and silencing a particular gene responsible for a cellular malfunction. Gene therapy is increasingly important, particularly in the field of cancer treatment. However, delivery of naked nucleic acids is hampered by their fast degradability inside the body and their polyanionic nature that inhibits the cellular uptake. There are many reports in the literature that have demonstrated that adsorption of nucleic acids onto positively charged Au NPs drastically reduced their degradability and helps their internalization into cells. This could be achieved, for example, by coating Au NPs with positively charged lysine amino acids [221] or with positively charged polymers [222– 225]. However, to ensure that the genetic material reaches the nucleus, more sophisticated constructions may be required. Such constructions may involve the use of PEI, a poly-cationic polymer able to escape endosomes because of the “proton sponge” effect causing membrane disruption [226], although it has been shown to be cytotoxic after a certain dose threshold. Hence, several authors have coated Au NPs with PEI to trap DNA or RNA, taking advantage of the endosomal escaping capacity of PEI, and substantially reducing its cytotoxicity [227–232]. Chen et al. have recently described a smart three-layered nanocarrier, based on the layer-by-layer (LBL) deposition of PEI/chitosan-aconitic anhydride (CS-Aco)/PEI/ shRNA (short/small hairpin RNA) onto Au NPs. CS-Aco was introduced as a pH-triggered chargereversible compound which hydrolyzed into positively charged CS once inside the lysosomes, causing the disassembly of the nanocarrier layers. The as-released Au-PEI NPs facilitated lysosomal membrane disruption and hence the successful delivery of shRNA-PEI into the cytoplasm [214]. Although PEI is particularly attractive for nucleic acids delivery, similar results have been achieved by other poly-cationic polymers adsorbed onto Au NPs [220, 233]. For instance, Lee and co-workers fabricated siRNA-loaded Au NPs using the LBL approach with alternating positively charged poly-L-lysine (PLL) and negatively charged siRNA. They successfully coated the Au NPs with four layers of PLL and three layers of siRNA, which were slowly released inside the cells by protease degradation of PLL and displayed gene silencing capability [234]. As already pointed out, another way of delivering DNA or RNA avoiding normal cell internalization pathways is adsorption onto naked Au NPs or projectiles and direct bombardment inside the cells using gene guns. This strategy is frequently used in plants, but nowadays it has also been explored for mammalian tissues [235, 236].\nDrug delivery is also an important field in which Au NPs are utilized. This field is of particular interest in the case of cancer treatment to avoid systemic toxicity during chemotherapy and to facilitate the delivery of hydrophobic drugs [237]. Indeed, the group of Rotello showed how to entrap two different hydrophobic drugs (tamoxifen and β-lapachone) in hydrophobic pockets created within alkanethiol monolayers surrounding Au NPs and their effective delivery\n[238]. Some other strategies involve the chemical modifications of drugs to link them covalently onto NPs, which could, in some cases, compromise the drug performance. Gibson et al. covalently functionalized Au NPs with approximately 70 molecules of anticancer drug paclitaxel per NP, but they did not report about the delivery and biological activity of the drug [239]. Nonetheless, most studies are based on systems to deliver doxorubicin (DOX) [240, 241], which is known for its properties for treating cancer, but also for its toxicity and side effects. The group of Li has recently reported high loading of PEGylated hollow Au nanospheres with DOX (up to 63% in weight) and their delivery after NIR light irradiation [242]. Apart from drugs, Au NPs have also been used as carriers for vaccines by decorating their surfaces with appropriate ligands (selected antigens and T-helper peptides) which were able to elicit an immunogenic response [243].\nInterestingly, Au NPs have been used not only as carriers but also as smart container openers. Plasmonic Au NPs were embedded in between polyelectrolyte layers in LBL constructed capsules carrying a therapeutic cargo within the capsule cavity. In a similar fashion, as explained before, irradiation of light onto those NPs led to the spatio-temporal controlled disassembly of the polymeric capsules producing the immediate cargo release [244–248].\nNowadays, all these delivery systems are evolving into more sophisticated constructions, which take advantage of the optical properties of Au NPs for combined drug therapy with photothermal ablation (PTA) and imaging [249] and in combination with other materials such as carbon [250, 251]. For instance, some recent reports along this dimension describe the wrapping of Au NPs or nanorods with hydrophilic graphene oxide nanosheets as carriers for gene therapy and improved PTA therapy [252–254]."
    }, {
      "heading" : "4.2 Au NPs as Active Therapeutic Agents",
      "text" : "When Au NPs act as therapeutic agents per se, several therapies can be distinguished depending on the NPs properties exploited. In the following we illustrate the wide range of potential therapies using Au NPs with some selected recent examples.\nOne of the most promising groups of therapeutic strategies using Au NPs are light-based therapies. These utilize the application of light to irradiate photosensible materials, whereby this light-activation is directly responsible for the desired therapeutic effects (i.e., destroying tumor cells). This group of lightbased therapies includes photothermal therapy (PTT), photodynamic therapy (PDT), and photoimmunotherapy (PIT) [255, 256]. Although PDT and PIT use a photosensitizer (i.e., light-activated drugs) for the release of reactive oxygen species (ROS) and the activation of immune responses, PTT is based on the use of photosensible materials (e.g., Au NPs) to generate local heat after being irradiated with electromagnetic radiation. The main difference between PIT and PDT is that in PIT monoclonal antibodies are associated with photosensitizers to improve the\nselective binding to the target tissues [255]. PTT has lately received more interest because it does not require oxygen to interact with the target cells or tissues and is able to use longer wavelength light, which is less energetic and therefore less harmful to other cells and tissues. PTT using Au NPs, also called plasmonic photothermal therapy (PPTT), exploits the unique LSPR properties of Au NPs. When an energy source such as electromagnetic radiation is applied, conversion to heat energy efficiently occurs in Au NPs because of electron excitation and subsequent non-radiative relaxation through electron–phonon and phonon–phonon coupling. This generated thermal energy can induce temperature increases of more than 20 C (i.e., hyperthermia), which can thereby induce tumor tissue ablation [255, 256].\nThere are several advantages of using Au NPs for PTT: (1) Au NPs have high absorption cross sections, and thus only minimal irradiation energy is required, (2) the conversion of light into heat is very fast (about 1 ps), (3) Au NPs are biocompatible, and (4) the ability of tuning the LSPR absorption (changing the size and shape of Au NPs) to absorb light in the visible up to the NIR region. Although visible light is successful in destroying cells labeled with spherical Au NPs, the NIR region is especially crucial to penetrate deep into tissues, with minimal attenuation by water and hemoglobin. The light can penetrate up to 10 cm in soft tissues in the “biological window” (650–900 nm), a region ideal for the LSPR absorption of Au nanoshells, nanorods, nanoprisms, and nanocages [28, 257]. When comparing the different NPs structures in terms of their applications in PTT, Au nanorods exhibit the best efficient NIR photothermal heat conversion. Although nanoshells have a larger absorption cross-section because of their larger size, and as a result they produce more heat, the nanorod shape has been shown to be twice as efficient in converting light radiation into thermal energy (photothermal efficiency) [258]. El-Sayed et al. determined the most effective Au nanorods size for PTT heat generation [259]. In this context, 28 8 nm Au nanorods were found to be the most effective, both in theoretical calculations and in in vitro experiments with human oral squamous cell carcinoma. Au nanorods in this dimension were the best compromise between the total light absorbed and the fraction that is converted into heat. Additionally, nanorods in this size led to an intense electromagnetic field that extends far enough from the NPs surface to allow for field coupling between NPs aggregates, resulting in enhanced experimental photothermal heating in solution. For example, Lin et al. [260] synthesized PEG-coated Au nanorods that showed enhanced PTT when used in the soft tissues of a genetically engineered mouse model (GEMM) of sarcoma. This model recapitulates the human disease more accurately in terms of structure and biology than subcutaneous xenograft models. This study represented a nice demonstration of a therapeutic, NPs-mediated thermal ablation protocol in a GEMM. Untargeted PEG-Au nanorods accumulated in the sarcomas at levels comparable to those in subcutaneous xenografts, providing evidence that passive targeting is indeed sufficient for PEG-Au nanorods to accumulate in a physiologic tumor microenvironment. Significant delays in tumor growth with no progression in some instances demonstrated the success of this method. A similar approach was used by Chen et al. [261], where PEG- Au\nnanocages could be passively delivered and accumulated into animal tumors, causing irreversible damage to tumor cells after exposure to NIR laser. Interestingly, PEG-Au nanocages were found not only on the surface but also in the core of the tumor.\nThere are increasing efforts to enhance therapeutic treatments by combining therapy methods that show synergistic effects, as in the case of PTT and PDT. For example, Choi et al. have reported a method which combines both phototherapies using Au nanorods-photosensitizer complexes and two different light sources to excite the photosensitizers and photothermal NPs separately because of their absorption mismatch [262]. In this work, the negatively charged photosensitizer Al(III) phthalocyanine chloride tetrasulfonic acid (AlPcS4) was attached onto the positively charged surface of Au nanorods by electrostatic interaction, and the photodynamic effect of the AlPcS4 photosensitizer was temporarily suppressed after complex formation with Au nanorods. In the intracellular environment the photosensitizer was released and it could finally be optically activated for phototherapeutic effect. Two different light sources were used to excite Au nanorods (810 nm laser) and AlPcS4 photosensitizer (675 nm laser) separately. Tumor growth was suppressed by 95% with PTT/PDT dual therapy, whereas the suppression was only 79% with PDT alone.\nThese examples successfully demonstrate the potential of NIR-active Au NPs for use in light-based therapies. The current challenge in these phototherapies is to increase the level of selectivity to act on tumor tissues with minimum damage to the surrounding healthy tissue. Furthermore, better control over bio-distribution and clearance are critical issues to be addressed.\nAu NPs are also used for enhanced X-ray radiotherapy. A challenge of X-ray radiation therapy in general is that high-dose X-rays under therapeutic conditions damage normal cells. Au NPs, upon X-ray irradiation, can act as dose enhancers and/or generate radicals that damage cancer cells and induce cell apoptosis. There are two main features of Au NPs which make them very good candidates for acting as X-ray radiosensitizers. First, Au has high number of protons (Z¼ 79) and neutrons, compared with the previous elements evaluated for dose enhancing such as iodine (Z¼ 53) and gadolinium (Z¼ 64). This translates into an increased photoelectric cross-section. Second, the size of Au NPs is critical for escaping the tumor vasculature using the enhanced permeability and retention (EPR) phenomena. Thus, Au NPs have been proposed as potential radiosensitizers for X-rays mediated cancer therapy, allowing for a reduction in X-ray dose with improved therapeutic results [263–266]. Yang et al. have recently demonstrated the potential effects of radiation-induced killing of melanoma cells as mediated by amphiphilic Au NPs embedded within the walls of lipid nanocapsules. Interestingly, the membrane-penetrating properties of these amphiphilic Au NPs allowed for significant enhancement of the radiotherapy efficiency, which opens a path for improving the efficacy of frontline radiotherapy treatments [264]. An additional way to improve the radiotherapeutic enhancement effects has been reported by using Au NPs with glucose (Glc) and PEG as ligands (PEG-Glc-Au NPs) [265]. The enormous reduction in tumor size after 47 days of treatment was also because of the role\nof PEG and Glc in improving uptake and bio-distribution, which led to a concentration of PEG-Glc-Au NPs in tumor tissue 20 times higher than in healthy cells 48 h after injection. Alternatively, the potential of Au NPs to aggregate within tumors can be exploited in this direction [266]. In addition, 15 nm Au NPs have been designed to aggregate and remain largely in the tumor, after direct intratumoral infusion, thus changing from NIR-transparent to NIR-absorbent, enabling tumor-specific heating upon NIR illumination. Aggregation within tumors seems to be induced by the lower pH of the tumor milieu and endosomes/lysosomes or other mechanisms, such as by labile ligand bonds and lysosomal enzymes. This aggregation effect, and subsequent heating by NIR followed by X-ray treatment, was able to reduce the X-ray dose needed for tumor control by a factor >3. Because of the limited penetration of NIR, certain superficial or accessible tumors (e.g., a subset of head, neck, and melanoma) would be immediate candidates to evaluate the potential of this strategy. These examples illustrate the huge potential of Au NPs to enhance radiotherapy treatments, providing useful insights for further clinical studies.\nIt is important to note that the mechanism by which Au NPs can lead to dose enhancements in radiation therapy differs when comparing photon and proton radiations for NPs excitation. The dose enhancement using protons can be up to 14% and is independent of proton energy, in contrast to photon excitation where the dose enhancement is highly dependent on the photon energy used. A theoretical Monte Carlo simulation study [267] concluded that the potential of Au NPs to enhance radiation therapy depends on the type of radiation source, and proton therapy can be enhanced significantly only if the Au NPs are in close proximity to target tissues.\nRadioactive Au NPs are being used to make radiation therapy more effective. The radioactive properties of 198Au (βmax¼ 0.96 MeV; half-life 2.7 days) make it an ideal candidate for use in radiotherapeutic applications [268]. A major challenge in cancer therapy has been delivery and retention, as it is necessary to increase the therapeutic payload to get an effective tumor treatment. In this regard, NPs containing radioactive isotopes can concentrate within the tumor and provide an opportunity to tune the radioactive therapeutic dose delivered to tumor cells. Furthermore, 198Au NPs have extraordinary tumor retention capabilities because of their natural affinity to leaky tumor vasculature. In this area, relevant advances have been achieved [268–270]. Khan et al. developed a method for the encapsulation of radioactive Au within a dendrimeric composite and demonstrated that radioactive Au NPs could deliver therapeutic doses to tumors [269]. More recently, gum arabic glycoprotein (GA)-functionalized Au NPs, consisting of beta-emitting 198Au, were used for reducing the sizes of inoperable prostate tumors [268, 270]. Interestingly, the optimum hydrophobicity of the GA matrix allowed for effective penetration across tumor membranes. The therapeutic efficacy of GA-198Au NPs was demonstrated in prostate tumor-bearing severely compromised immunodeficient (SCID) mice models, reaching an unprecedented 82%, 3 weeks after single-dose intratumoral administration of GA-198Au NPs (408 μCi). The findings of significant therapeutic efficacy, good in vivo tolerance, and\nnon-toxic features make these NPs potentially ideal candidates for future human applications.\nRadiofrequency (RF) fields can be used to induce Au NP-mediated thermal ablation in a similar manner to that of photothermal and radio-sensitization therapies. The efficiency of RF-based therapy is significantly enhanced by using Au NPs, which are accumulated in the tumor area and then absorb main RF radiation power to heat cancer cells and thus cause their selective destruction. In particular, an intense source of RF radiation with frequency of 13.6 MHz and the power of 600 W induced the heating of suspensions of Au NPs with a heating rate of ~20 K/s, which resulted in considerable cell necrosis [271]. The NPs heating mechanism in an RF field is a very complex phenomenon. Glazer et al. have demonstrated that Au NPs heat primarily via Joule heating [271, 272]. Briefly, the Au NPs are hypothesized to function as tiny resistors, where free electrons on the surface have restricted movements. Therefore the friction created at the individual NP level releases heat into the surrounding aqueous solution [273].\nThe potential use of Au NPs coupled to RF waves was evaluated for the treatment of human hepatocellular and pancreatic cancer cells [274]. Direct injection of citrate-Au NPs into the tumor allowed focusing of the RF waves (13.56 MHz RF field) for selective heating of cancer cells. The resulting induced heat was lethal to these cancer cells bearing Au NPs in vitro. It was also demonstrated that the Au NPs had no intrinsic cytotoxicity or antiproliferative effects in the two human cancer cell lines studied. In another example, Curley et al. designed a method using Au NPs functionalized with the epidermal growth factor receptor (EGFR) inhibitor cetuximab in Panc-1 (pancreatic adenocarcinoma) and Difi (colorectal adenocarcinoma) cells which express high levels of EGFR [275]. This method proved to be cytotoxic to nearly 100% of the pancreatic and colorectal cells, but hardly any of the cells from the control group were damaged. The advantages of this therapy are that shortwave (megahertz range) RF energy is non-ionizing, penetrates deeply into biological tissues with no adverse side effects, and heats Au NPs efficiently. Thus, this technique may represent an effective treatment for numerous human malignant diseases using non-invasive RF hyperthermia.\nThe finding that Au NPs are able to inhibit angiogenesis (i.e., the formation of new vessels in organs or tissues) has also opened a new path to control the growth and spread of cancerous tissues via angiogenesis therapy. One method to inhibit angiogenesis in vivo is to block the function of pro-angiogenic heparin-binding growth factors (HB-GFs) such as vascular endothelial growth factor 165 (VEGF165) and basic fibroblast growth factor (bFGF). Mukherjee et al. demonstrated that Au NPs inhibit VEGF165-induced proliferation of endothelial cells in a dose-dependent manner [276]. This inhibition effect was tested in vivo using a nude mouse ear model, showing that after a week of daily intraperitoneal injections, the ascites volume had reduced in the NPs treated mice compared to the non-treated tumor-bearing mice. More recently, detailed studies of the antiangiogenic properties of Au NPs concluded that Au NPs not only inhibit VEGF165-induced HUVEC (Human Umbilical Vein Endothelial Cells) proliferation but also repress endothelial cell migration and tube formation [277]. Using Au NPs of different sizes and\nsurface charges, it was demonstrated that a naked Au NPs surface is required and that the core size plays an important role to inhibit the function of heparin-binding growth factors (HB-GFs) and subsequent intracellular signaling events. Furthermore, the inhibitory effect of Au NPs was produced by the change in HB-GFs conformation/configuration (denaturation) by the NPs, whereas the conformations of non-HB-GFs remained unaffected [278]. The antiangiogenic properties of Au NPs have also been exploited for the treatment of chronic inflammatory diseases such as rheumatoid arthritis. Intra-articular delivery of Au NPs has been demonstrated to be an effective treatment strategy for collagen-induced arthritis [279]."
    }, {
      "heading" : "5 Use of Au NPs Towards Theranostics",
      "text" : "Recent research has paved the way for multimodal ‘theranostic’ (i.e., a combination of therapy and diagnosis) nanocarriers designed for carrying out simultaneous detection/diagnosis and treatment of the disease following administration [184, 280–282]. Au NPs are suitable for developing theranostic NPs thanks to their unique characteristics that enable their use as contrast agents, as therapeutic entities, and as scaffolds to adhere functional molecules, therapeutic cargoes (e.g., drugs/genes), and targeting ligands [184, 281]. Several examples of Au-based theranostic NPs are illustrated in Fig. 3, which are explained below.\nAu-based theranostic NPs that utilize light-based techniques for monitoring and treating diseases are of special interest as they allow for spatially and temporally controllable drug release, localized therapy, and minimally invasive treatment modalities that reduce patients discomfort [282]. An interesting photo-triggered theranostic system has been developed by Khlebtsov et al. [283], consisting of a silver/gold (Ag/Au) nanocage core surrounded by a silica shell containing the NIR photosensitizer Yb–2,4-dimethoxyhematoporphyrin (Yb–HP) for monitoring tumors and simultaneous dual therapy, i.e., PTT/PDT (Fig. 3a). A significant higher death rate of HeLa cervical cancer cells was observed in vitro when they were incubated with the composite NPs and irradiated by 630-nm light because of PTT by the Ag/Au NPs as well as PDT using the presence of Yb-HP. Furthermore, the IR luminescence of Yb-HP (900–1060 nm, originating from Yb3þ ions, and located in the tissue transparency window) could be used for diagnostic purposes and for controlling the accumulation and bio-distribution of the composite NPs in tumors. Another example of theranostic NPs for simultaneous X-rays/ CT dual-imaging and dual-mode enhanced radiation therapy (RT) and PTT was reported by Huan et al. [284]. Folic acid-conjugated and silica-modified Au nanorods were synthesized and showed highly selective targeting, excellent X-ray/CT imaging ability, and enhanced RT and PTT effects (Fig. 3b). These multifunctional NPs could specifically bind to folate receptors on the surface of MGC803 gastric cancer cells and were imaged in vivo using both X-ray and CT imaging followed by treatment via RT or PTT. Alternatively, activatable theranostic NPs were developed by using\nAu@Ag/Au NPs assembled with activatable aptamer probes, which provided highcontrast image-guided site-specific PTT therapy [287]. The Au@Ag/Au NPs simultaneously serve as an optical heater and a fluorescence quencher. The activatable aptamer probes comprised a thiolated aptamer and a fluorophore-labeled complementary DNA. Thus, the activatable theranostic NPs with quenched fluorescence in the free state could undergo signal activation through target binding-induced conformational change of the activatable aptamer probes in specific tumor tissues, and then achieve on-demand treatment under image-guided irradiation. By using S6 aptamer as a model, in vitro and in vivo studies of A549 lung cancer cells verified\nthat these NPs greatly improved imaging contrast and specific destruction. This strategy might be explored as a versatile platform for simultaneous detection and treatment of multiple kinds of cancer cells with the use of specific aptamers for varying cancer targets.\nConde et al. [285] recently developed an interesting Au-based theranostic system capable of intersecting all RNA pathways: from gene specific downregulation to silencing the silencers, i.e., siRNA and miRNA pathways (Fig. 3c). The system consists of Au NPs functionalized with a fluorophore labeled hairpin-DNA, which allows one to downregulate a specific gene directly and also to silence single gene expression, exogenous siRNA, and endogenous miRNAs, simultaneously tracking cell internalization and identifying the cells where silence is occurring (i.e., the fluorescence signal is directly proportional to the level of silencing). The usefulness of this approach was demonstrated for silencing an endogenous miRNA (miR-21) commonly upregulated in cancer, such as in colorectal carcinoma cells (HCT-116). The photothermal properties of Au NPs can also be used to generate transient vapor nano-bubbles to produce a tunable nanoscale theranostic agent, described as PNBs [286]. These PNBs are generated when Au NPs are locally overheated with short laser pulses because of the evaporation of a very thin volume of the surrounding medium, which in turn creates a vapor nanobubble that expands and collapses within nanoseconds. The bubble scatters the light, thus acting as an optical probe which allows for tumor detection, and the fast expansion of the PNB produces a localized mechanical impact which damages cell membranes, resulting in cell death, and therefore acting as a therapeutic agent. This novel theranostic system has been successfully applied as an in vivo tunable theranostic cellular agent in zebrafish hosting prostate cancer xenografts, presenting higher therapeutic selectivity when compared with Au NPs alone [288]. Au NPs conjugated with anti-EGFR antibody C225 could actively target EGFR-positive A549 lung carcinoma cells. Following cellular uptake, single human prostate cancer cells could be detected and ablated under optical guidance in vivo by tunable PNBs in a single theranostic procedure. By varying the energy of the laser pulse, the PNBs size could be dynamically tuned in a theranostic sequence of two PNBs: an initial small PNB detected a cancer cell through optical scattering, followed by a second bigger PNB, which mechanically ablated this cell without damaging the surrounding tissues, and its optical scattering confirmed the destruction of the cells. This innovative and promising theranostic strategy concept of a ‘cell theranostics’ approach that unites diagnosis, therapy, and confirmation (guidance) of the results of therapy in a single process at cellular level principally can help to improve both the rapidity and the precision of treatment [288]. Recently, the same group has used this concept for both, localized delivery of molecular cargo as well as mechanical destruction of cells by generation of a transient PNB around the Au NPs with a single incident laser pulse. Small PNBs can create a transient hole on the cell membrane to ‘inject’ molecular cargo without damage to the cells. Large PNBs, on the other hand, can cause mechanical destruction of the cells of interest [289] (Fig. 3d).\nBased on these examples, it is apparent that theranostic Au NPs have opened the door to novel and advanced treatment strategies that combine therapeutics with diagnostics, aiming to monitor the response to treatment and increase drug efficacy and safety, which would be a key part of personalized medicine."
    }, {
      "heading" : "6 Applications of Au NPs in Clinical Trials",
      "text" : "Some of the above-mentioned medical applications using Au NPs are already in the stage of pre-clinical or clinical trials.\nThe diagnostics company “Nanosphere” has developed the so-called Nanosphere’s Verigene® System, which utilizes advanced automation and Au NPs to enable rapid direct detection of nucleic acids and high-sensitivity protein detection on the same platform. This technology has already received food and drug administration (FDA) approval in the United States. It is based on Au NPs of 13–20 nm diameter functionalized with either a defined number of oligonucleotides (i.e., short pieces of DNA or RNA) or a defined number of antibodies specific to a particular protein of interest.\nOne therapy using Au NPs which has reached clinical trials is CYT-6091, 27 nm citrate-coated Au NPs conjugated with thiolated-PEG and tumor necrosis factor-α (TNF-α) (Aurimmune; CytImmune Sciences). The NPs have the dual effect of increasing tumor targeting and tumor toxicity in comparison with the use of TNF-α alone [290]. In this trial the side effects and best dose of CYT-6091 in treating patients with advanced solid tumors by intravenous administration have been studied [291]. Future clinical studies should focus on combining CYT-6091 with approved chemotherapies for the systemic treatment of non-resectable cancers.\nUsing the same CYT-6091 NPs, another clinical trial has been carried out to evaluate the tissue distribution and the selective tumor trafficking of CYT-6091 in patients with primary and metastatic cancers [292]. Patients, stratified according to cancer type, received CYT-6091 and then underwent standard-care surgery. Tumor and normal tissues were removed during surgery for analysis of antitumor effects and tissue distribution of CYT-6091 by electron microscopy.\nAu nanoshells (AuroShells®, Nanospectra Biosciences), which consist of a silica core of 120 nm diameter with a 15-nm gold shell, were used in clinical trials to treat head and neck cancers using PPTT. This therapy, called AuroLase® Therapy, consisted of an injection of Au nanoshell NPs into the patient’s bloodstream. After 12–24 h (enough time for the NPs to accumulate inside the tumor), an 808 nm IR laser was used to heat the NPs and destroy tumor cells [293]. These NPs are currently under clinical trials in patients with primary and/or metastatic lung cancer where there is airway obstruction. In this study, patients are given a systemic infusion of NPs and a subsequently escalating dose of laser radiation delivered by an optical fiber via bronchoscopy.\nIn the treatment of atherosclerotic lesions, two delivery techniques for NPs and PPTT are under clinical trials (NANOM FIM) [294]. Patients underwent nano-\nintervention either with the delivery of silica-Au NPs in a mini-surgery implanted bioengineered on-artery patch, or with the delivery of silica-Au iron-bearing NPs with targeted micro-bubbles or stem cells by means of magnetic navigation system vs stent implantation. The primary results showed a similar degree of regression of total atheroma volume after 12 months for both approaches of delivery.\nAnother technique being tested in pre-clinical trials works is on validating polyvalent Au NPs functionalized with RNAi (RNA interference) as anti-glioma therapeutics [295]. This nano-RNAi platform can be used to target signature lesions of glioblastoma, which play an important role in driving glioma pathogenesis, mediating therapeutic resistance, and instigating neurologically debilitating necrogenesis. RNAi-Au NPs are being validated onmultiple levels, using glioma stem cell cultures, derived xenografts, and genetically engineered glioma mouse models.\nDespite these examples, the full clinical impact of Au NP-based therapies is not yet known. There is clearly a need to translate already developed applications to clinical trials in a timely but safe manner."
    }, {
      "heading" : "7 Concluding Remarks and Future Outlook",
      "text" : "We have discussed novel strategies for the synthesis and functionalization of Au NPs to evaluate their potential use in nanomedicine. In addition, their detection and sensing properties have been explored for diagnosing some diseases. Au NPs either alone or in hybrid form can also improve the performance of practically used imaging techniques. Moreover, Au NP-based therapies are generally superior in terms of specificity, selectivity, efficiency, and cytotoxicity compared to the same methods without Au NPs. Additionally, Au composite NPs have recently been evaluated for their theranostic potential both in vitro and in vivo. Nowadays, the main focus is the transition of Au NPs from laboratories to the clinics. Though the initial theranostic efficacy of Au NPs shows promising results, there are still many challenges which need to be addressed before their use in clinical practice. The first challenge involves the long-term retention, cytotoxicity, and ultimate renal clearance of the NPs. Though the biodistribution and toxicity of Au NPs have been extensively studied, reliable predictions based on these results are rare. Therefore, more studies need to be performed to ensure their safety before use in humans. The biodistribution of Au NPs is dependent on their size, geometry and surface chemistry. Dissimilarities of reported results dealing with Au NPs of the same size and shape have been attributed to the type of coating or stabilizing agents used. In order to overcome this problem, strategies to improve comparability and standardization of nanotoxicological studies are needed. Moreover, there should be a shift of the focus of toxicological experiments from ‘live–dead’ assays to the assessment of cell function, allowing observation of bioresponses at lower doses, which are more relevant for in vivo scenarios. Second, detection and sensing of analytes in complex biological fluids (such as urine, blood, etc.) are still complicated to achieve. Third, non-invasive clinical trials at the molecular level need to be better explored. Fourth,\nthe development of personalized medicines for the treatment of individual patients according to their genetic profiles is so far merely a vision described in scientific papers. Last, but not least, vaccinations based on Au NPs for humans and/or animals against biologically active factors or diseases still remain a dream to be fulfilled. Addressing these and other such types of challenges may help in the future to shift Au NP-based nanomedicines further into clinics.\nAcknowledgments This work was supported by the European Commission (project Futurenanoneeds to WJP). SA, BP, and CCC acknowledge the Alexander von Humboldt Foundation for a PostDoc fellowship. QZ acknowledges CSC for funding. MGS acknowledges the Youssef Jameel Foundation for a PhD fellowship. AE acknowledges Junta de Andalucia for a Talentia Postdoc Fellowship, co-financed by the European Union’s Seventh Framework Programme, grant agreement no 267226. MC acknowledges a Research Fellow Grant from Ikerbasque, Basque Foundation for Science."
    } ],
    "references" : [ {
      "title" : "Gold-Based Nanomaterials for Applications in Nanomedicine",
      "author" : [ "S Petersen", "S Barcikowski" ],
      "venue" : "J Phys Chem C 113:19830",
      "citeRegEx" : "23",
      "shortCiteRegEx" : "23",
      "year" : 2009
    }, {
      "title" : "Nano Lett 14:6955  Gold-Based Nanomaterials for Applications in Nanomedicine",
      "author" : [ "GK Joshi", "S Deitz-McElyea", "M Johnson", "S Mali", "M Korc", "R Sardar" ],
      "venue" : null,
      "citeRegEx" : "105",
      "shortCiteRegEx" : "105",
      "year" : 2014
    }, {
      "title" : "Merkoçi A (2012",
      "author" : [ "M Maltez-da Costa", "A de la Escosura-Mu~niz", "C Nogués", "L Barrios", "E Ibá~nez" ],
      "venue" : null,
      "citeRegEx" : "131",
      "shortCiteRegEx" : "131",
      "year" : 2012
    }, {
      "title" : "Nanotechnology 23:075102  Gold-Based Nanomaterials for Applications in Nanomedicine",
      "author" : [ "H Yuan", "CG Khoury", "H Hwang", "CM Wilson", "GA Grant", "T Vo-Dinh" ],
      "venue" : null,
      "citeRegEx" : "182",
      "shortCiteRegEx" : "182",
      "year" : 2012
    }, {
      "title" : "Recent Pat Endocr Metab Immune Drug Discovery",
      "author" : [ "EJ Sanchez-Barcelo", "MD Mediavilla" ],
      "venue" : null,
      "citeRegEx" : "255",
      "shortCiteRegEx" : "255",
      "year" : 2014
    }, {
      "title" : "ACS Nano 8:8992  Gold-Based Nanomaterials for Applications in Nanomedicine",
      "author" : [ "Y-S Yang", "RP Carney", "F Stellacci", "DJ Irvine" ],
      "venue" : null,
      "citeRegEx" : "264",
      "shortCiteRegEx" : "264",
      "year" : 2014
    }, {
      "title" : "Arthritis Rheum 56:544",
      "author" : [ "Tsai C-Y", "Shiau A-L", "Chen S-Y", "Chen Y-H", "Cheng P-C", "Chang M-Y", "Chen D-H", "Chou C-H", "Wang C-R", "Wu C-L" ],
      "venue" : null,
      "citeRegEx" : "279",
      "shortCiteRegEx" : "279",
      "year" : 2007
    }, {
      "title" : "ASCO annual meeting proceedings",
      "author" : [ "S Libutti", "G Paciotti", "L Myer", "R Haynes", "W Gannon", "M Walker", "G Seidel", "A Byrnes", "N Yuldasheva", "L Tamarkin" ],
      "venue" : null,
      "citeRegEx" : "291",
      "shortCiteRegEx" : "291",
      "year" : 2009
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "Thus, here we aim to provide an overview of some of the most recent achievements in the synthesis of Au NPs using wet- chemistry (though also other routes such as laser ablation exist [23]).",
      "startOffset" : 184,
      "endOffset" : 188
    }, {
      "referenceID" : 1,
      "context" : "Recent advances in the detection of microRNAs (miRNAs) by Au nanoprisms without the need for labels [105] and in the sensing of trace oligonucleotides biomarkers [106] have also been reported.",
      "startOffset" : 100,
      "endOffset" : 105
    }, {
      "referenceID" : 2,
      "context" : "Cancer circulating cells have been sensed by combining the specific labeling through antibody-modified Au NPs and the sensitivity of the Au NPs-electro-catalyzed hydrogen evolution reaction (HER) detection technique [131].",
      "startOffset" : 216,
      "endOffset" : 221
    }, {
      "referenceID" : 3,
      "context" : "When Au NPs are excited with femtosecond pulsed lasers whose resonance frequency matches with the LSPR band of the Au NPs, two photon absorption occurs which results in two photon luminescence from the Au NPs [182, 193, 195].",
      "startOffset" : 209,
      "endOffset" : 224
    }, {
      "referenceID" : 3,
      "context" : "The contrast of Au nanostars conjugated with wheat germ agglutinin in TPL-based imaging can be utilized for imaging their uptake [182].",
      "startOffset" : 129,
      "endOffset" : 134
    }, {
      "referenceID" : 4,
      "context" : "This group of lightbased therapies includes photothermal therapy (PTT), photodynamic therapy (PDT), and photoimmunotherapy (PIT) [255, 256].",
      "startOffset" : 129,
      "endOffset" : 139
    }, {
      "referenceID" : 4,
      "context" : "selective binding to the target tissues [255].",
      "startOffset" : 40,
      "endOffset" : 45
    }, {
      "referenceID" : 4,
      "context" : ", hyperthermia), which can thereby induce tumor tissue ablation [255, 256].",
      "startOffset" : 64,
      "endOffset" : 74
    }, {
      "referenceID" : 5,
      "context" : "Interestingly, the membrane-penetrating properties of these amphiphilic Au NPs allowed for significant enhancement of the radiotherapy efficiency, which opens a path for improving the efficacy of frontline radiotherapy treatments [264].",
      "startOffset" : 230,
      "endOffset" : 235
    }, {
      "referenceID" : 6,
      "context" : "Intra-articular delivery of Au NPs has been demonstrated to be an effective treatment strategy for collagen-induced arthritis [279].",
      "startOffset" : 126,
      "endOffset" : 131
    }, {
      "referenceID" : 7,
      "context" : "In this trial the side effects and best dose of CYT-6091 in treating patients with advanced solid tumors by intravenous administration have been studied [291].",
      "startOffset" : 153,
      "endOffset" : 158
    } ],
    "year" : 2015,
    "abstractText" : "In this review, an overview of the current state-of-the-art of gold-based nanomaterials (Au NPs) in medical applications is given. The unique properties of Au NPs, such as their tunable size, shape, and surface characteristics, optical properties, biocompatibility, low cytotoxicity, high stability, and multifunctionality potential, among others, make them highly attractive in many aspects of medicine. First, the preparation methods for various Au NPs including functionalization strategies for selective targeting are summarized. Second, recent progresses on their applications, ranging from the diagnostics to therapeutics are highlighted. Finally, the rapidly growing and promising field of gold-based theranostic nanoplatforms is discussed. Considering the great body of existing information and the high speed of its renewal, we chose in this review to generalize the data that have been accumulated during the past few years for the most promising directions in the use of Au NPs in current medical research. S. Ashraf (*), B. Pelaz, M.G. Soliman, Q. Zhang, and C. Carrillo-Carrion (*) Fachbereich Physik, Philipps Universität Marburg, 35037 Marburg, Germany e-mail: ashraf@staff.uni-marburg.de; carolina.carrillocarrion@physik.uni-marburg.de P. del Pino CIC biomaGUNE, San Sebastian, Spain M. Carril CIC biomaGUNE, San Sebastian, Spain Ikerbasque, Basque Foundation for Science, 48011 Bilbao, Spain A. Escudero Fachbereich Physik, Philipps Universität Marburg, 35037 Marburg, Germany Instituto de Ciencia de Materiales de Sevilla, CSIC-University of Seville, 41092 Seville, Spain W.J. Parak Fachbereich Physik, Philipps Universität Marburg, 35037 Marburg, Germany CIC biomaGUNE, San Sebastian, Spain",
    "creator" : "Arbortext Advanced Print Publisher 9.0.223/W Unicode"
  }
}